Organigram Global (STU:0OG) Asset Turnover: 0.12 (As of Mar. 2026)


STU:0OG Organigram Global Inc STU:0OG
64 GF Score
Price €0.88
GF Value €1.47
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Organigram Global Asset Turnover?

Organigram Global STU:0OG +7.60% 64 Asset Turnover is 0.12 as of Mar. 2026. GuruFocus rates STU:0OG with a GF Score™ of 64/100 and a GF Value™ of €1.47 (Possible Value Trap). The stock has 1 warning sign investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Organigram Global's Revenue for the three months ended in Mar. 2026 was €37.7 Mil. Organigram Global's Total Assets for the quarter that ended in Mar. 2026 was €328.6 Mil. Therefore, Organigram Global's Asset Turnover for the quarter that ended in Mar. 2026 was 0.12.

Asset Turnover is linked to ROE % through Du Pont Formula. Organigram Global's annualized ROE % for the quarter that ended in Mar. 2026 was -1.00%. It is also linked to ROA % through Du Pont Formula. Organigram Global's annualized ROA % for the quarter that ended in Mar. 2026 was -0.71%.


Organigram Global  (STU:0OG) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Organigram Global's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-2.324/231.566
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-2.324 / 150.792)*(150.792 / 328.5955)*(328.5955/ 231.566)
=Net Margin %*Asset Turnover*Equity Multiplier
=-1.54 %*0.4589*1.419
=ROA %*Equity Multiplier
=-0.71 %*1.419
=-1.00 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Organigram Global's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=-2.324/328.5955
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-2.324 / 150.792)*(150.792 / 328.5955)
=Net Margin %*Asset Turnover
=-1.54 %*0.4589
=-0.71 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Organigram Global Asset Turnover Related Terms


Organigram Global Asset Turnover Historical Data

* Premium members only.

The historical data trend for Organigram Global's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organigram Global Asset Turnover Chart

Organigram Global Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24 Sep25
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.16 0.27 0.30 0.52

Organigram Global Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.13 0.14 0.12 0.12

STU:0OG vs ZTS: Asset Turnover Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organigram Global Asset Turnover vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Organigram Global's Asset Turnover falls into.


STU:0OG
64GF Score
Organigram Global Inc STU:0OG
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organigram Global Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Organigram Global's Asset Turnover for the fiscal year that ended in Sep. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Sep. 2025 )/( (Total Assets (A: Sep. 2024 )+Total Assets (A: Sep. 2025 ))/ count )
=159.624/( (271.284+346.251)/ 2 )
=159.624/308.7675
=0.52

Organigram Global's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=37.698/( (328.521+328.67)/ 2 )
=37.698/328.5955
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.12 mean?
Organigram Global (STU:0OG) has a Asset Turnover of 0.12 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Organigram Global and its competitors.
Is Organigram Global's Asset Turnover too high?
Organigram Global's current Asset Turnover is 0.12. Overall, Organigram Global has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Organigram Global's Asset Turnover compare to ZTS?
Organigram Global's Asset Turnover of 0.12 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Drug Manufacturers company?
A good Asset Turnover depends on the Drug Manufacturers industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Organigram Global and its competitors. Organigram Global's current Asset Turnover is 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organigram Global stock overvalued right now?
Based on GuruFocus' analysis, Organigram Global (STU:0OG) is currently considered Possible Value Trap. The stock's GF Value™ is €1.47, compared to a current price of €0.88 — trading 40.3% below its estimated fair value. The current Asset Turnover is 0.12. Organigram Global's overall GF Score™ is 64/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Organigram Global (STU:0OG), the current Asset Turnover is 0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organigram Global (STU:0OG) Overvalued in 2026?

Based on GuruFocus' analysis, Organigram Global stock appears to be undervalued. The current stock price of €0.88 is trading 40.3% below its estimated GF Value™ of €1.47. GuruFocus considers Organigram Global to be Possible Value Trap.

Key valuation signals for STU:0OG:

  • Asset Turnover: 0.12
  • GF Value™: €1.47 vs. price of €0.88 (40.3% below fair value)
  • GF Score™: 64/100 with 1 warning sign

No single metric tells the full story. See the STU:0OG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Organigram Global Business Description

Other Exchanges OGI:USAOGI:Canada
Address 145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
64GF Score

Get the complete analysis for STU:0OG

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.88
Price
€1.47
GF Value